Green Alpha Advisors, LLC Editas Medicine, Inc. Transaction History

Green Alpha Advisors, LLC

  • $87.2 Million
  • Q2 2025

A detailed history of Green Alpha Advisors, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 170,782 shares of EDIT stock, worth $391,090. This represents 0.43% of its overall portfolio holdings.

Number of Shares
170,782
Previous 183,903 7.13%
Holding current value
$391,090
Previous $229,000 63.76%
% of portfolio
0.43%
Previous 0.29%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$0.98 - $2.35 $12,858 - $30,834
-13,121 Reduced 7.13%
170,782 $375,000
Q1 2025

Apr 09, 2025
BUY
$1.14 - $3.2 $82,393 - $231,280
72,275 Added 64.75%
183,903 $229,000
Q4 2024

Jan 13, 2025
BUY
$1.2 - $3.76 $81,954 - $256,789
68,295 Added 157.61%
111,628 $141,000
Q3 2024

Oct 07, 2024
BUY
$3.39 - $5.96 $44,293 - $77,873
13,066 Added 43.17%
43,333 $147,000
Q2 2024

Aug 13, 2024
SELL
$4.67 - $7.28 $73,870 - $115,155
-15,818 Reduced 34.32%
30,267 $141,000
Q1 2024

Apr 09, 2024
BUY
$7.03 - $11.07 $1,145 - $1,804
163 Added 0.35%
46,085 $341,000
Q4 2023

Jan 04, 2024
SELL
$6.25 - $11.11 $195,412 - $347,365
-31,266 Reduced 40.51%
45,922 $465,000
Q3 2023

Oct 10, 2023
BUY
$6.92 - $9.31 $106,173 - $142,843
15,343 Added 24.81%
77,188 $602,000
Q2 2023

Jul 06, 2023
BUY
$6.36 - $11.47 $20,186 - $36,405
3,174 Added 5.41%
61,845 $508,000
Q1 2023

Apr 06, 2023
SELL
$7.03 - $11.53 $6,917 - $11,345
-984 Reduced 1.65%
58,671 $425,000
Q4 2022

Jan 12, 2023
BUY
$8.32 - $13.21 $23,770 - $37,740
2,857 Added 5.03%
59,655 $0
Q3 2022

Oct 14, 2022
SELL
$12.16 - $19.42 $3.44 Million - $5.5 Million
-283,146 Reduced 83.29%
56,798 $695,000
Q2 2022

Jul 08, 2022
BUY
$9.99 - $21.35 $2.91 Million - $6.22 Million
291,531 Added 602.18%
339,944 $4.02 Million
Q1 2022

Apr 19, 2022
BUY
$14.08 - $27.63 $171,761 - $337,058
12,199 Added 33.69%
48,413 $921,000
Q4 2021

Jan 12, 2022
BUY
$26.55 - $40.57 $120,855 - $184,674
4,552 Added 14.38%
36,214 $961,000
Q3 2021

Oct 12, 2021
BUY
$39.27 - $72.94 $28,941 - $53,756
737 Added 2.38%
31,662 $1.3 Million
Q2 2021

Jul 22, 2021
BUY
$31.29 - $56.64 $637,439 - $1.15 Million
20,372 Added 193.04%
30,925 $1.75 Million
Q1 2021

Jul 22, 2021
BUY
$39.71 - $90.58 $179,370 - $409,149
4,517 Added 74.83%
10,553 $443,000
Q4 2020

Jul 22, 2021
BUY
$27.07 - $84.35 $163,394 - $509,136
6,036 New
6,036 $423,000

Others Institutions Holding EDIT

# of Institutions
220
Shares Held
47M
Call Options Held
365K
Put Options Held
354K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $157M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email